Gala Renee D insider trades
Gala Renee D has filed 30 Form 4s with the SEC that we hold, for Jazz Pharmaceuticals plc (JAZZ) (President & CEO, Director), Dexcom INC (DXCM) (Director) and Gossamer Bio, Inc. (GOSS) (Director). Across all of them we count 0 purchases worth $0 and 4 sales worth $2.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($958.9K). The largest single trade was a sale of 6,000 shares of Jazz Pharmaceuticals plc worth $790.5K, dated 2023-05-18. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-03-09 and the latest 2026-10-07.
Jazz Pharmaceuticals plc (JAZZ)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-12-21 | S, sale reported on Form 4 | 2,635 | $421.6K | 2022-12-22 |
| 2023-05-18 | S, sale reported on Form 4 | 6,000 | $790.5K | 2023-05-19 |
| 2026-09-08 | S, sale reported on Form 4 | 2,000 | $486.1K | 2026-09-10 |
| 2026-10-06 | S, sale reported on Form 4 | 2,000 | $472.8K | 2026-10-07 |
Dexcom INC (DXCM)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Gossamer Bio, Inc. (GOSS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1607737) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms